Body Compartment Pharmacokinetics of Anti-retroviral Agents That May be Used for Future HIV Post-exposure Prophylaxis Regimens.
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2019
Price : $35 *
At a glance
- Drugs Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide (Primary) ; Darunavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms PEP2
- 06 Feb 2019 Planned End Date changed from 15 Jan 2019 to 15 Dec 2019.
- 06 Feb 2019 Planned primary completion date changed from 15 Jan 2019 to 15 Dec 2019.
- 18 Apr 2018 Status changed from not yet recruiting to recruiting.